4 Stocks Pushing The Health Services Industry Higher

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 115 points (-0.8%) at 13,894 as of Monday, Feb. 4, 2013, 11:49 AM ET. The NYSE advances/declines ratio sits at 654 issues advancing vs. 2,230 declining with 132 unchanged.

The Health Services industry currently sits down 0.9% versus the S&P 500, which is down 0.9%. On the negative front, top decliners within the industry include Thermo Fisher Scientific ( TMO), down 2.6%, Life Technologies ( LIFE), down 2.2%, Waters Corporation ( WAT), down 2.3%, Stryker Corporation ( SYK), down 1.3% and DaVita HealthCare Partners ( DVA), down 1.2%.

TheStreet Ratings group would like to highlight 4 stocks pushing the industry higher today:

4. Opko Health ( OPK) is one of the companies pushing the Health Services industry higher today. As of noon trading, Opko Health is up $0.28 (4.2%) to $7.01 on average volume Thus far, 1.4 million shares of Opko Health exchanged hands as compared to its average daily volume of 2.0 million shares. The stock has ranged in price between $6.70-$7.03 after having opened the day at $6.80 as compared to the previous trading day's close of $6.73.

Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies primarily in the United States, Chile, and Mexico. Opko Health has a market cap of $1.9 billion and is part of the health care sector. Shares are up 33.5% year to date as of the close of trading on Friday. Currently there are 3 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income and feeble growth in the company's earnings per share. Get the full Opko Health Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

3. As of noon trading, Cyberonics ( CYBX) is up $4.30 (9.7%) to $48.65 on heavy volume Thus far, 1.2 million shares of Cyberonics exchanged hands as compared to its average daily volume of 444,900 shares. The stock has ranged in price between $45.00-$48.93 after having opened the day at $45.22 as compared to the previous trading day's close of $44.35.

Cyberonics, Inc. engages in the design, development, marketing, and sale of implantable medical devices. Cyberonics has a market cap of $1.2 billion and is part of the health care sector. The company has a P/E ratio of 29.1, above the S&P 500 P/E ratio of 17.7. Shares are down 17.5% year to date as of the close of trading on Friday. Currently there are 7 analysts that rate Cyberonics a buy, 1 analyst rates it a sell, and 2 rate it a hold.

TheStreet Ratings rates Cyberonics as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, compelling growth in net income and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Cyberonics Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

2. As of noon trading, Humana ( HUM) is up $3.51 (4.7%) to $78.86 on heavy volume Thus far, 3.0 million shares of Humana exchanged hands as compared to its average daily volume of 2.0 million shares. The stock has ranged in price between $75.02-$79.96 after having opened the day at $75.68 as compared to the previous trading day's close of $75.35.

Humana Inc. operates as a health care company that offers a range of insurance products and health and wellness services that incorporate an integrated approach to lifelong well-being. Humana has a market cap of $11.8 billion and is part of the health care sector. The company has a P/E ratio of 9.9, below the S&P 500 P/E ratio of 17.7. Shares are up 8.3% year to date as of the close of trading on Friday. Currently there are 15 analysts that rate Humana a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Humana as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and attractive valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Humana Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

1. As of noon trading, St Jude Medical ( STJ) is up $0.23 (0.6%) to $41.40 on light volume Thus far, 1.1 million shares of St Jude Medical exchanged hands as compared to its average daily volume of 4.4 million shares. The stock has ranged in price between $40.94-$41.66 after having opened the day at $41.50 as compared to the previous trading day's close of $41.17.

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. St Jude Medical has a market cap of $12.5 billion and is part of the health care sector. The company has a P/E ratio of 11.7, below the S&P 500 P/E ratio of 17.7. Shares are up 12.6% year to date as of the close of trading on Friday. Currently there are 12 analysts that rate St Jude Medical a buy, no analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates St Jude Medical as a hold. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we find that the stock has experienced relatively poor performance when compared with the S&P 500 during the past year. Get the full St Jude Medical Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

If you are interested in one of these 4 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

A reminder about TheStreet Ratings group: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

null

More from Markets

Asian Markets Decline in Morning Trading

Asian Markets Decline in Morning Trading

Verizon Proves Resilient in Sell-Off; Decoding the Facebook Short -- ICYMI

Verizon Proves Resilient in Sell-Off; Decoding the Facebook Short -- ICYMI

Three Big Factors That Rocked the Stock Market Tuesday

Three Big Factors That Rocked the Stock Market Tuesday

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call